Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
437.00
-4.7 (-1.06%)
BSENSE

May 08

BSE+NSE Vol: 7.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Akums Drugs
Strides Pharma
Sanofi India
Shilpa Medicare
Viyash Scientifi
Marksans Pharma
P & G Health Ltd
Blue Jet Health
Aarti Pharma
FDC
Sudeep Pharma

Why is Shilpa Medicare Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.57%
  • Poor long term growth as Net Sales has grown by an annual rate of 9.42% and Operating profit at 12.62% over the last 5 years
2
With a growth in Net Sales of 10.75%, the company declared Very Positive results in Dec 25
  • The company has declared positive results for the last 10 consecutive quarters
  • ROCE(HY) Highest at 8.57%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 10.70 times
  • NET SALES(Q) Highest at Rs 409.73 cr
3
With ROCE of 8, it has a Fair valuation with a 3 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 37.22%, its profits have risen by 124.6% ; the PEG ratio of the company is 0.4
4
Majority shareholders : Non Institution
5
Consistent Returns over the last 3 years
  • Along with generating 37.22% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Shilpa Medicare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shilpa Medicare for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shilpa Medicare
37.45%
0.99
37.73%
Sensex
-3.74%
-0.28
13.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
9.42%
EBIT Growth (5y)
12.62%
EBIT to Interest (avg)
2.22
Debt to EBITDA (avg)
4.13
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.42
Tax Ratio
21.09%
Dividend Payout Ratio
0
Pledged Shares
8.73%
Institutional Holding
19.66%
ROCE (avg)
4.59%
ROE (avg)
2.48%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
46
Industry P/E
35
Price to Book Value
3.49
EV to EBIT
33.25
EV to EBITDA
23.22
EV to Capital Employed
3.02
EV to Sales
6.34
PEG Ratio
0.37
Dividend Yield
0.11%
ROCE (Latest)
8.01%
ROE (Latest)
6.73%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
ROCE(HY)

Highest at 8.57%

OPERATING PROFIT TO INTEREST(Q)

Highest at 10.70 times

NET SALES(Q)

Highest at Rs 409.73 cr

PBDIT(Q)

Highest at Rs 114.30 cr.

PBT LESS OI(Q)

Highest at Rs 72.90 cr.

PAT(Q)

Highest at Rs 54.00 cr.

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Shilpa Medicare

Operating Profit to Interest - Quarterly
Highest at 10.70 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 72.90 cr has Grown at 60.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 45.52 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 409.73 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 409.73 cr has Grown at 22.2% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 335.38 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 114.30 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 72.90 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 54.00 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 54.00 cr has Grown at 31.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 40.98 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)